ANVISA-2020-0025-V425
Type II variation for application ANVISA-2020-0025. Type II variation: Container Closure Change for Immunovant-α — routine update
Variation Number
ANVISA-2020-0025-V425
Type
Type II
Application
Change
Status
Overdue
Fee
€72,958
Submitted
—
Approved
—
Description
Type II variation: Container Closure Change for Immunovant-α — routine update